Assessing the Impact of US Food and Drug Administration Breakthrough Therapy Designation Timing on Trial Characteristics and Development Speed.

Persons

Aaron Seth Kesselheim

Venue / Journal

Clin Pharmacol Ther

Date

Fri, 10/01/2021 - 12:00

Additional Journal Information

110(4):1018-1024

Authors

Pregelj L, Hine DC, Kesselheim AS, Darrow JJ.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/34048058